STOK
Price
$32.39
Change
-$0.70 (-2.12%)
Updated
Dec 12 closing price
Capitalization
1.85B
88 days until earnings call
Intraday BUY SELL Signals
TARA
Price
$5.70
Change
-$0.31 (-5.16%)
Updated
Dec 12 closing price
Capitalization
294.3M
88 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

STOK vs TARA

Header iconSTOK vs TARA Comparison
Open Charts STOK vs TARABanner chart's image
Stoke Therapeutics
Price$32.39
Change-$0.70 (-2.12%)
Volume$1.17M
Capitalization1.85B
Protara Therapeutics
Price$5.70
Change-$0.31 (-5.16%)
Volume$700.49K
Capitalization294.3M
STOK vs TARA Comparison Chart in %
STOK
Daily Signal:
Gain/Loss:
TARA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
STOK vs. TARA commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STOK is a Hold and TARA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (STOK: $33.09 vs. TARA: $6.01)
Brand notoriety: STOK and TARA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: STOK: 85% vs. TARA: 211%
Market capitalization -- STOK: $1.85B vs. TARA: $294.3M
STOK [@Biotechnology] is valued at $1.85B. TARA’s [@Biotechnology] market capitalization is $294.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

STOK’s FA Score shows that 1 FA rating(s) are green whileTARA’s FA Score has 1 green FA rating(s).

  • STOK’s FA Score: 1 green, 4 red.
  • TARA’s FA Score: 1 green, 4 red.
According to our system of comparison, STOK is a better buy in the long-term than TARA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STOK’s TA Score shows that 6 TA indicator(s) are bullish while TARA’s TA Score has 3 bullish TA indicator(s).

  • STOK’s TA Score: 6 bullish, 4 bearish.
  • TARA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, STOK is a better buy in the short-term than TARA.

Price Growth

STOK (@Biotechnology) experienced а +6.57% price change this week, while TARA (@Biotechnology) price change was -12.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Reported Earning Dates

STOK is expected to report earnings on Mar 11, 2026.

TARA is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STOK($1.85B) has a higher market cap than TARA($294M). STOK YTD gains are higher at: 200.000 vs. TARA (13.826). STOK has higher annual earnings (EBITDA): 29.1M vs. TARA (-59.43M). STOK has more cash in the bank: 248M vs. TARA (133M). STOK has less debt than TARA: STOK (2.91M) vs TARA (3.66M). STOK has higher revenues than TARA: STOK (206M) vs TARA (0).
STOKTARASTOK / TARA
Capitalization1.85B294M629%
EBITDA29.1M-59.43M-49%
Gain YTD200.00013.8261,447%
P/E Ratio47.63N/A-
Revenue206M0-
Total Cash248M133M186%
Total Debt2.91M3.66M80%
FUNDAMENTALS RATINGS
STOK vs TARA: Fundamental Ratings
STOK
TARA
OUTLOOK RATING
1..100
764
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
21
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
4696
PRICE GROWTH RATING
1..100
3537
P/E GROWTH RATING
1..100
4100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TARA's Valuation (21) in the null industry is somewhat better than the same rating for STOK (82). This means that TARA’s stock grew somewhat faster than STOK’s over the last 12 months.

TARA's Profit vs Risk Rating (100) in the null industry is in the same range as STOK (100). This means that TARA’s stock grew similarly to STOK’s over the last 12 months.

STOK's SMR Rating (46) in the null industry is somewhat better than the same rating for TARA (96). This means that STOK’s stock grew somewhat faster than TARA’s over the last 12 months.

STOK's Price Growth Rating (35) in the null industry is in the same range as TARA (37). This means that STOK’s stock grew similarly to TARA’s over the last 12 months.

STOK's P/E Growth Rating (4) in the null industry is significantly better than the same rating for TARA (100). This means that STOK’s stock grew significantly faster than TARA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
STOKTARA
RSI
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 10 days ago
85%
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
Bearish Trend 24 days ago
85%
Bearish Trend 16 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
STOK
Daily Signal:
Gain/Loss:
TARA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PFHO1.050.05
+5.00%
Pacific Health Care Organization, Inc.
BJCHF0.34N/A
N/A
Beijing Capital International Airport Co., Ltd.
LTRCF3.43N/A
N/A
LOTTERY CORP LTD
FHGDF0.12N/A
N/A
Founder Holdings Ltd.
LLDTF1.13N/A
N/A
Lloyds Banking Group plc

STOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STOK has been loosely correlated with QTTB. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if STOK jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STOK
1D Price
Change %
STOK100%
-3.10%
QTTB - STOK
49%
Loosely correlated
-4.79%
NGNE - STOK
48%
Loosely correlated
+2.41%
SYRE - STOK
46%
Loosely correlated
-0.87%
KURA - STOK
46%
Loosely correlated
-2.61%
RGNX - STOK
43%
Loosely correlated
-1.61%
More

TARA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TARA has been loosely correlated with RGNX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TARA jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TARA
1D Price
Change %
TARA100%
+4.70%
RGNX - TARA
41%
Loosely correlated
-1.61%
SYRE - TARA
41%
Loosely correlated
-0.87%
AMLX - TARA
40%
Loosely correlated
-1.21%
DNLI - TARA
39%
Loosely correlated
-1.14%
TBPH - TARA
38%
Loosely correlated
+0.40%
More